Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease forms
© 2023. The Author(s)..
Knowledge on the pathogenesis of FL is mainly based on data derived from advanced/systemic stages of FL (sFL) and only small cohorts of localized FL (lFL) have been characterized intensively so far. Comprehensive analysis with profiling of somatic copy number alterations (SCNA) and whole exome sequencing (WES) was performed in 147 lFL and 122 sFL. Putative targets were analyzed for gene and protein expression. Overall, lFL and sFL, as well as BCL2 translocation-positive (BCL2+) and -negative (BCL2-) FL showed overlapping features in SCNA and mutational profiles. Significant differences between lFL and sFL, however, were detected for SCNA frequencies, e.g., in 18q-gains (14% lFL vs. 36% sFL; p = 0.0003). Although rare in lFL, gains in 18q21 were associated with inferior progression-free survival (PFS). The mutational landscape of lFL and sFL included typical genetic lesions. However, ARID1A mutations were significantly more often detected in sFL (29%) compared to lFL (6%, p = 0.0001). In BCL2 + FL mutations in KMT2D, BCL2, ABL2, IGLL5 and ARID1A were enriched, while STAT6 mutations more frequently occurred in BCL2- FL. Although the landscape of lFL and sFL showed overlapping features, molecular profiling revealed novel insights and identified gains in 18q21 as prognostic marker in lFL.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:37 |
|---|---|
| Enthalten in: |
Leukemia - 37(2023), 10 vom: 10. Okt., Seite 2058-2065 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kalmbach, Sabrina [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Journal Article |
|---|
| Anmerkungen: |
Date Completed 04.10.2023 Date Revised 30.11.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41375-023-01995-w |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM360628710 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM360628710 | ||
| 003 | DE-627 | ||
| 005 | 20231226083423.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41375-023-01995-w |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1202.xml |
| 035 | |a (DE-627)NLM360628710 | ||
| 035 | |a (NLM)37563306 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kalmbach, Sabrina |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease forms |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.10.2023 | ||
| 500 | |a Date Revised 30.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. The Author(s). | ||
| 520 | |a Knowledge on the pathogenesis of FL is mainly based on data derived from advanced/systemic stages of FL (sFL) and only small cohorts of localized FL (lFL) have been characterized intensively so far. Comprehensive analysis with profiling of somatic copy number alterations (SCNA) and whole exome sequencing (WES) was performed in 147 lFL and 122 sFL. Putative targets were analyzed for gene and protein expression. Overall, lFL and sFL, as well as BCL2 translocation-positive (BCL2+) and -negative (BCL2-) FL showed overlapping features in SCNA and mutational profiles. Significant differences between lFL and sFL, however, were detected for SCNA frequencies, e.g., in 18q-gains (14% lFL vs. 36% sFL; p = 0.0003). Although rare in lFL, gains in 18q21 were associated with inferior progression-free survival (PFS). The mutational landscape of lFL and sFL included typical genetic lesions. However, ARID1A mutations were significantly more often detected in sFL (29%) compared to lFL (6%, p = 0.0001). In BCL2 + FL mutations in KMT2D, BCL2, ABL2, IGLL5 and ARID1A were enriched, while STAT6 mutations more frequently occurred in BCL2- FL. Although the landscape of lFL and sFL showed overlapping features, molecular profiling revealed novel insights and identified gains in 18q21 as prognostic marker in lFL | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Proto-Oncogene Proteins c-bcl-2 |2 NLM | |
| 700 | 1 | |a Grau, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Zapukhlyak, Myroslav |e verfasserin |4 aut | |
| 700 | 1 | |a Leich, Ellen |e verfasserin |4 aut | |
| 700 | 1 | |a Jurinovic, Vindi |e verfasserin |4 aut | |
| 700 | 1 | |a Hoster, Eva |e verfasserin |4 aut | |
| 700 | 1 | |a Staiger, Annette M |e verfasserin |4 aut | |
| 700 | 1 | |a Kurz, Katrin S |e verfasserin |4 aut | |
| 700 | 1 | |a Weigert, Oliver |e verfasserin |4 aut | |
| 700 | 1 | |a Gaitzsch, Erik |e verfasserin |4 aut | |
| 700 | 1 | |a Passerini, Verena |e verfasserin |4 aut | |
| 700 | 1 | |a Engelhard, Marianne |e verfasserin |4 aut | |
| 700 | 1 | |a Herfarth, Klaus |e verfasserin |4 aut | |
| 700 | 1 | |a Beiske, Klaus |e verfasserin |4 aut | |
| 700 | 1 | |a Micci, Francesca |e verfasserin |4 aut | |
| 700 | 1 | |a Möller, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Bernd, Heinz-Wolfram |e verfasserin |4 aut | |
| 700 | 1 | |a Feller, Alfred C |e verfasserin |4 aut | |
| 700 | 1 | |a Klapper, Wolfram |e verfasserin |4 aut | |
| 700 | 1 | |a Stein, Harald |e verfasserin |4 aut | |
| 700 | 1 | |a Hansmann, Martin-Leo |e verfasserin |4 aut | |
| 700 | 1 | |a Hartmann, Sylvia |e verfasserin |4 aut | |
| 700 | 1 | |a Dreyling, Martin |e verfasserin |4 aut | |
| 700 | 1 | |a Holte, Harald |e verfasserin |4 aut | |
| 700 | 1 | |a Lenz, Georg |e verfasserin |4 aut | |
| 700 | 1 | |a Rosenwald, Andreas |e verfasserin |4 aut | |
| 700 | 1 | |a Ott, German |e verfasserin |4 aut | |
| 700 | 1 | |a Horn, Heike |e verfasserin |4 aut | |
| 700 | 0 | |a German Lymphoma Alliance (GLA) |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Leukemia |d 1989 |g 37(2023), 10 vom: 10. Okt., Seite 2058-2065 |w (DE-627)NLM012593788 |x 1476-5551 |7 nnns |
| 773 | 1 | 8 | |g volume:37 |g year:2023 |g number:10 |g day:10 |g month:10 |g pages:2058-2065 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41375-023-01995-w |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 37 |j 2023 |e 10 |b 10 |c 10 |h 2058-2065 | ||